The Patent Finder

Terms ending in 2036

Roche Molecular Systems, Inc.

Every in-force patent on Roche Molecular Systems, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,059,993Oligonucleotides for Controlling Amplification of Nucleic Acids
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 10,871,425Systems and Methods for Meso-Dissection
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 11,181,449Systems and Methods for Meso-Dissection
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 11,860,072Systems and Methods for Meso-Dissection
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 10,612,009Polymerase Variants
In force
 · High confidence
Roche Sequencing Solutions, Inc.In forceHigh confidence
US 10,961,520Polymerase Variants
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 10,087,490Compositions and Methods for Detection of Drug Resistant Mycobacterium Tuberculosis
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 9,909,169Allele-Specific Amplification of Nucleic Acids Using Blocking Oligonucleotides for Wild Type Suppression
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 10,421,999Targeted Sequencing and UID Filtering
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
US 9,939,429Device and Method for Biological Sample Collection and Inspection
In force
 · High confidence
Roche Molecular Systems, Inc.In forceHigh confidence
33 more term ends in 2036 · Pro
10 of 43 patents shown. Soonest term end first, then patent number.
Pro members see all 43.
Upgrade to Pro
39 of these are in force and held by Roche Molecular Systems, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited